ENLIBI
LIVE

Serial Number

99374409

Owner

Teva Pharmaceuticals International GmbH

Attorney

Lori Wolfe

Filing Date

Sep 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ENLIBI Trademark

Serial Number: 99374409

ENLIBI is a trademark filed by Teva Pharmaceuticals International GmbH on September 4, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Teva Pharmaceuticals International GmbH (103 trademarks)

Schlüsselstrasse 12

Entity Type: 98

Trademark Details

Filing Date

September 4, 2025

Registration Date

Not Registered

Published for Opposition

March 3, 2026

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2026 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 4, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 4, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 4, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 4, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 4, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 4, 2026 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 20, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 4, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2025 NWOS
NEW APPLICATION ENTERED
Sep 4, 2025 NWAP